Literature DB >> 11964050

Incidence of chromosomal imbalances in advanced colorectal carcinomas and their metastases.

Thomas Knösel1, Simone Petersen, Holger Schwabe, Karsten Schlüns, Ulrike Stein, Peter Michael Schlag, Manfred Dietel, Iver Petersen.   

Abstract

Comparative genomic hybridization (CGH) was used to screen 54 advanced colon carcinomas. i.e., 24 primary tumors and 30 metastases, for chromosomal alterations. Using a sensitive statistical method for the determination of DNA imbalances and histograms for analysis of the incidence of changes, we identified the DNA over-representation of chromosome 20q as the most common alteration being present in 100% of cases. High incidence deletions were observed on 18q21-18q23 (96%), 4q27-4q28 (96%), 4p14 (87%), 5q21 (81%), 1p21-1p22 (72%), 21q21 (74%), 6q16 (72%), 3p12 (66%), 8p24-8p21 (66%), 9p21 (64%), 11q22 (64%), and 14q13-14q21 (64%). Further frequent over-representation was found on 7q12-7q11.2 (75%), 16p11-16p12 (70%), 19p13 (70%), 9q34 (67%), 19q13 (67%), 13q34 (64%), 13q13 (64%), 17q21 (59%), 22q11 (61%), 8q24 (57%), and 1q21 (57%). Pronounced DNA gains and losses being defined as regions in which the ratio profiles exceeded the values of 1.5 and 0.5, respectively, frequently colocalized with peaks of incidence curve. The use of difference histograms for the comparison of tumor subgroups as well as case-by-case histogram for the analysis of 15 paired tumor samples identified several of the above alterations as relevant for tumor progression and metastasis formation. The study identified additional loci and delineates more precisely those that have been previously reported. For comparative purposes, we have made our primary data (ratio profiles, clinicopathological parameters, histograms) available at the interactive web site http://amba.charite.de/cgh, where the incidence of changes can be determined at individual loci and additional parameters can be applied for the analysis of our CGH results.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11964050     DOI: 10.1007/s004280100493

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  31 in total

1.  Down-regulation of Bax-interacting factor 1 in human pancreatic ductal adenocarcinoma.

Authors:  Domenico Coppola; James Helm; Msoumeh Ghayouri; Mokenge P Malafa; Hong-Gang Wang
Journal:  Pancreas       Date:  2011-04       Impact factor: 3.327

2.  Identification of Fat4 as a candidate tumor suppressor gene in breast cancers.

Authors:  Chao Qi; Yiwei Tony Zhu; Liping Hu; Yi-Jun Zhu
Journal:  Int J Cancer       Date:  2009-02-15       Impact factor: 7.396

3.  HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer.

Authors:  Khawla Al-Kuraya; Hedvika Novotny; Prashant Bavi; Abdul K Siraj; Shahab Uddin; Adnan Ezzat; Nasser Al Sanea; Fouad Al-Dayel; Hadeel Al-Mana; Salwa S Sheikh; Martina Mirlacher; Coya Tapia; Ronald Simon; Guido Sauter; Luigi Terracciano; Luigi Tornillo
Journal:  J Clin Pathol       Date:  2006-08-01       Impact factor: 3.411

4.  Prognostic impact of S100A9 overexpression in non-small cell lung cancer.

Authors:  Hideki Kawai; Yoshihiro Minamiya; Naoko Takahashi
Journal:  Tumour Biol       Date:  2011-03-03

5.  Detection of APC gene deletions in colorectal malignancies using quantitative PCR in a Chinese population.

Authors:  Zhengyu Fang; Yi Xiong; Jiana Li; Li Liu; Manhui Li; Wei Zhang; Lei Shi; Jun Wan
Journal:  Pathol Oncol Res       Date:  2011-02-26       Impact factor: 3.201

6.  Human papillomavirus DNA and oncogene alterations in colorectal tumors.

Authors:  Luis Orlando Pérez; Gisela Barbisan; Anabel Ottino; Horacio Pianzola; Carlos Daniel Golijow
Journal:  Pathol Oncol Res       Date:  2010-03-17       Impact factor: 3.201

7.  Bax-interacting factor-1 expression in prostate cancer.

Authors:  Domenico Coppola; Cecilia Oliveri; Zena Sayegh; David Boulware; Yoshinori Takahashi; Julio Pow-Sang; Julie Y Djeu; Hong-Gang Wang
Journal:  Clin Genitourin Cancer       Date:  2008-09       Impact factor: 2.872

8.  [Comparison of chromosomal defects in primary tumor and metastases by comparative genomic hybridization (CGH)].

Authors:  F Simon; M Vogt; C Kuhnen; G Johnen; K-M Müller
Journal:  Pathologe       Date:  2005-07       Impact factor: 1.011

9.  Down-regulation of Bax-interacting factor-1 in colorectal adenocarcinoma.

Authors:  Domenico Coppola; Farah Khalil; Steven A Eschrich; David Boulware; Timothy Yeatman; Hong-Gang Wang
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

10.  Chromosomal alterations during lymphatic and liver metastasis formation of colorectal cancer.

Authors:  Thomas Knösel; Karsten Schlüns; Ulrike Stein; Holger Schwabe; Peter Michael Schlag; Manfred Dietel; Iver Petersen
Journal:  Neoplasia       Date:  2004 Jan-Feb       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.